Gastrointestinal Disorders

The new approval for risankizumab makes it the only interleukin-23 inhibitor for moderately to severely active Crohn disease, according to AbbVie.

Dupilumab is approved for the treatment of eosinophilic esophagitis in patients aged ≥12 years weighing at least 40 kgs.

In a new study of patients with cirrhosis, over two-thirds of outpatient clinic visits that included an opioid prescription were with primary care physicians.

IDWeek 2021: A new study found that only 16% of patients with CDI rehospitalized for recurrent infection had been seen in follow-up 30 days after original discharge.

IDWeek 2021: Use of vancomycin vs metronidazole increased after the 2017 IDSA recommendation but CDI recurrence rates increased slightly, investigators report.

Helicobacter pylori infection in early-middle-aged adults was associated with higher BMI, triglyceride levels, carotid plaque formation, and carotid intima-media thickness.

Intermittent pain causing the child to cry and an episode of bright red rectal bleeding are described by the mother. Review labs and imaging: What's your diagnosis?

The 2021 American College of Gastroenterology guidelines on management of C. difficile reflect an expanding body of evidence for preventing, diagnosing, and treating the dangerous infection.

The investigational, live biotherapeutic demonstrated superior efficacy vs placebo in reduction of recurrent Clostridioides difficile infection in ~100 patients at 8-week follow-up.

Patients interested in optimizing their own gut health have typically tried several approaches before they ask a clinician for help. Two specialists offer seasoned guidance on what helps most.